Weight gain, a common adverse reaction of VPA, has been associated with leptin receptor (LEPR) and ankyrin repeat kinase domain containing 1 (ANKK1) gene polymorphisms in a cohort of Han Chinese people with epilepsy [180]. Here, ANKK1 is linked to epilepsy.